[Chronic pharyngitis. Modern approaches to diagnosis and treatment].
Tovmasyan AS, Filina EV, Golubeva LI, Golovatyuk AA, Ramazanov SR, Polyaeva MY, Kishinevskii AE, Shvedov NV, Mosin VV.
Vestn Otorinolaringol. 2023;88(3):56-62. doi: 10.17116/otorino20228803156.
[CAUSES AND PECULIARITIES OF DEVELOPMENT OF CHRONIC ATROPHIC PHARYNGITIS].
Jikhashvili N.
Georgian Med News. 2020 Jan;(298):33-36.
[Histomorphology of chronic hypertrophic and atrophic pharyngitis].
SCEVOLA P, LEONARDELLI GB.
Arch Ital Otol Rinol Laringol. 1954 Jan-Feb;65(1):72-86.
[The role of microbiota in chronic pharyngitis].
Kryukov AI, Kunel'skaya VY, Shadrin GB, Bessarab TP, Machulin AI, Krasnikova DI, Andreenkova OA.
Vestn Otorinolaringol. 2018;83(3):61-64. doi: 10.17116/otorino201883361.
[Atrophic pharyngitis and silicosis].
OTTOBONI A, CIURLO E.
Minerva Otorinolaringol. 1955 Jan-Feb;5(1):11-4.
[Results of use of a propolis extract for chronic subatrophic and atrophic pharyngitis].
Kravchuk PA.
Zh Ushn Nos Gorl Bolezn. 1971 Jan-Feb;31(1):73-8.
[Mucopolysaccharide substances and glycogen in chronic hypertrophic and atrophic pharyngitis. Histochemical contribution].
Stucchi GF, Zerba L.
Ann Laringol Otol Rinol Faringol. 1966 Mar-Apr;65(2):243-55.
[A new approach to the evaluation of the state of the microcirculatory system in patients presenting with chronic atrophic pharyngitis and treated with a synthetic neuropeptide].
Boldyreva OV, Burenkov GI, Toropova LA.
Vestn Otorinolaringol. 2011;(3):18-9.
[Prospects for the use of ozone therapy and low-intensity laser therapy in the treatment of atrophic pharyngitis].
Kryukov AI, Pogonchenkova IV, Kulikov AG, Tovmasyan AS, Filina EV, Schepkina EV, Kuznetsov AI, Tarakanova OV.
Vestn Otorinolaringol. 2024;89(4):4-13. doi: 10.17116/otorino2024890414.
[The effectiveness of bromhexine in the complex treatment of chronic subatrophic and atrophic pharyngitis].
Sharifbaev AS, Dzhaloletdinov TSh.
Vestn Otorinolaringol. 1988 Mar-Apr;(2):45-7.
